Heron Therapeutics Revenue and Competitors

Location

$224M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Heron Therapeutics's estimated annual revenue is currently $49.2M per year.(i)
  • Heron Therapeutics's estimated revenue per employee is $274,930
  • Heron Therapeutics's total funding is $224M.

Employee Data

  • Heron Therapeutics has 179 Employees.(i)
  • Heron Therapeutics grew their employee count by -30% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M50%N/AN/A
#4
$2.3M129%N/AN/A
#5
$1.4M8-20%N/AN/A
#6
N/A740%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.5M129%N/AN/A
Add Company

Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.

keywords:N/A

$224M

Total Funding

179

Number of Employees

$49.2M

Revenue (est)

-30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Heron Therapeutics's People

NameTitleEmail/Phone
1
Director, Acute Care, Scientific Communications and Medical AffairsReveal Email/Phone
2
Executive Director- National Accounts and Oncology SalesReveal Email/Phone
3
Executive Director, Assistant General Counsel & Assistant SecretaryReveal Email/Phone
4
Territory Business ManagerReveal Email/Phone
5
Territory Business ManagerReveal Email/Phone
6
Director, Market Access MarketingReveal Email/Phone
7
Louisiana Territory ManagerReveal Email/Phone
8
Territory Business ManagerReveal Email/Phone
9
Senior Northeast Area Business ManagerReveal Email/Phone
10
Territory Business ManagerReveal Email/Phone

Heron Therapeutics News

2022-04-17 - Zacks: Brokerages Expect Heron Therapeutics, Inc. (NASDAQ ...

Zacks: Brokerages Expect Heron Therapeutics, Inc. (NASDAQ:HRTX) to Announce -$0.45 EPS. Posted by admin on Apr 18th, 2022.

2022-04-13 - $25.61 Million in Sales Expected for Heron Therapeutics, Inc ...

Three analysts have issued estimates for Heron Therapeutics' earnings. The lowest sales estimate is $21.00 million and the highest is $32.82...

2022-03-30 - Heron Therapeutics: Cash Is A Problem Again

It's been almost a year since my previous article on Heron Therapeutics (NASDAQ:HRTX) and while the company made progress, the stock is...

2019-09-08 - Why Heron Therapeutics, Inc. (HRTX)’s Stock Is Melting Down -4.67% Today

Today's big question for investors is, “what's going on with Heron Therapeutics, Inc. (NASDAQ:HRTX) stock? Its price is nose-diving -0.86 ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$51.1M179-16%N/A
#2
$28.2M17946%N/A
#3
$36M17916%N/A
#4
$65.3M17913%N/A
#5
$24.1M18010%N/A